Article Details

Seattle biotech firm Silverback Therapeutics sets terms for IPO, looks to raise up to $151M

Retrieved on: 2020-11-30 16:07:30

Tags for this article:

Click the tags to see associated articles and topics

Seattle biotech firm Silverback Therapeutics sets terms for IPO, looks to raise up to $151M. View article details on hiswai:

Excerpt

... areas of disease in a way designed to avoid damaging healthy tissue. ... state company to go public this year, following <b>health tech</b> startup Accolade, ...

Article found on: www.geekwire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up